1,084
Participants
Start Date
July 31, 2023
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2027
PEGylated recombinant human interferon alpha-2b injection
Continuous combination therapy: pegylated interferon alpha-2b 180µg, subcutaneously once a week for 96 weeks, combined with NAs throughout the treatment period.
PEGylated recombinant human interferon alpha-2b injection
Pulsed combination therapy: pegylated interferon alpha-2b 180µg once weekly by subcutaneous injection for 8 weeks with 4 weeks off for a total treatment duration of 96 weeks, combined with NAs throughout the treatment period.
RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
The First Affiliated Hospital, University of Science and Technology of China
OTHER
The Second Hospital of Anhui Medical University
OTHER
Chaohu Hospital of Anhui Medical University
OTHER
The First Affiliated Hospital of Bengbu Medical University
OTHER
Anhui Medical University
OTHER